|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:RPL13-MAPKAPK3 (FusionGDB2 ID:75915) |
Fusion Gene Summary for RPL13-MAPKAPK3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RPL13-MAPKAPK3 | Fusion gene ID: 75915 | Hgene | Tgene | Gene symbol | RPL13 | MAPKAPK3 | Gene ID | 28998 | 7867 |
| Gene name | mitochondrial ribosomal protein L13 | MAPK activated protein kinase 3 | |
| Synonyms | L13|L13A|L13mt|RPL13|RPML13 | 3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MDPT3|MK-3|MK3 | |
| Cytomap | 8q24.12 | 3p21.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 39S ribosomal protein L13, mitochondrialMRP-L13mitochondrial large ribosomal subunit protein uL13m | MAP kinase-activated protein kinase 3MAPKAP kinase 3chromosome 3p kinasemitogen-activated protein kinase-activated protein kinase 3 | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | . | Q16644 | |
| Ensembl transtripts involved in fusion gene | ENST00000311528, ENST00000393099, ENST00000452368, ENST00000567815, | ENST00000357955, ENST00000497283, ENST00000446044, | |
| Fusion gene scores | * DoF score | 19 X 18 X 4=1368 | 2 X 2 X 2=8 |
| # samples | 20 | 2 | |
| ** MAII score | log2(20/1368*10)=-2.77399632511117 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: RPL13 [Title/Abstract] AND MAPKAPK3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | RPL13(89629431)-MAPKAPK3(50683209), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | RPL13-MAPKAPK3 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. RPL13-MAPKAPK3 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. RPL13-MAPKAPK3 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. RPL13-MAPKAPK3 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | MAPKAPK3 | GO:0018105 | peptidyl-serine phosphorylation | 15850461 |
| Tgene | MAPKAPK3 | GO:0034097 | response to cytokine | 8774846 |
| Fusion gene breakpoints across RPL13 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across MAPKAPK3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | AA524181 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
Top |
Fusion Gene ORF analysis for RPL13-MAPKAPK3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000311528 | ENST00000357955 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000311528 | ENST00000497283 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000393099 | ENST00000357955 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000393099 | ENST00000497283 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000452368 | ENST00000357955 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000452368 | ENST00000497283 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000567815 | ENST00000357955 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| 5CDS-intron | ENST00000567815 | ENST00000497283 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| Frame-shift | ENST00000311528 | ENST00000446044 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| Frame-shift | ENST00000393099 | ENST00000446044 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| Frame-shift | ENST00000567815 | ENST00000446044 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| In-frame | ENST00000452368 | ENST00000446044 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000452368 | RPL13 | chr16 | 89629431 | - | ENST00000446044 | MAPKAPK3 | chr3 | 50683209 | - | 3010 | 1315 | 1242 | 1766 | 174 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000452368 | ENST00000446044 | RPL13 | chr16 | 89629431 | - | MAPKAPK3 | chr3 | 50683209 | - | 0.011241778 | 0.9887582 |
Top |
Fusion Genomic Features for RPL13-MAPKAPK3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for RPL13-MAPKAPK3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:89629431/chr3:50683209) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | MAPKAPK3 |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression. {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:15563468, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:20599781, ECO:0000269|PubMed:8626550, ECO:0000269|PubMed:8774846}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 44_304 | 0 | 383.0 | Domain | Protein kinase | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 44_304 | 0 | 383.0 | Domain | Protein kinase | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 335_344 | 0 | 383.0 | Motif | Nuclear export signal (NES) | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 350_353 | 0 | 383.0 | Motif | Bipartite nuclear localization signal 1 | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 364_368 | 0 | 383.0 | Motif | Bipartite nuclear localization signal 2 | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 335_344 | 0 | 383.0 | Motif | Nuclear export signal (NES) | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 350_353 | 0 | 383.0 | Motif | Bipartite nuclear localization signal 1 | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 364_368 | 0 | 383.0 | Motif | Bipartite nuclear localization signal 2 | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 50_58 | 0 | 383.0 | Nucleotide binding | ATP | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 50_58 | 0 | 383.0 | Nucleotide binding | ATP | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 307_343 | 0 | 383.0 | Region | Autoinhibitory helix | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000357955 | 0 | 11 | 345_369 | 0 | 383.0 | Region | p38 MAPK-binding site | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 307_343 | 0 | 383.0 | Region | Autoinhibitory helix | |
| Tgene | MAPKAPK3 | chr16:89629431 | chr3:50683209 | ENST00000446044 | 0 | 13 | 345_369 | 0 | 383.0 | Region | p38 MAPK-binding site |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for RPL13-MAPKAPK3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >75915_75915_1_RPL13-MAPKAPK3_RPL13_chr16_89629431_ENST00000452368_MAPKAPK3_chr3_50683209_ENST00000446044_length(transcript)=3010nt_BP=1315nt TTTCCGCTCGGCTGTTTTCCTGCGCAGGAGCCGCAGGGCCGTAGGCAGCCATGGCGCCCAGCCGGAATGGCATGGTCTTGAAGCCCCACT TCCACAAGGACTGGCAGCGGCGCGTGGCCACGTGGTTCAACCAGCCGGCCCGTAAGATCCGCAGACGTAAGGCCCGGCAAGCCAAGGCGC GCCGCATCGCCCCGCGCCCCGCGTCGGGTCCCATCCGGCCCATCGTGCGCTGCCCCACGGTTCGGTACCACACGAAGGTGCGCGCCGGCC GCGGCTTCAGCCTGGAGGAGCTCAGGGTGGCCGGCATTCACAAGAAGGGAGACAGTTCTGCTGAAGAACTGAAACTGGCCACCCAGCTGA CCGGACCGGTCATGCCCGTCCGGAACTGTTGAAAAGAAAAAATAAAGCCCTCCTGGGGACTTGGAATCAGTCGGCAGTCATGCTGGGTCT CCACGTGGTGTGTTTCGTGGGAACAACTGGGCCTGGGATGGGGCTTCACTGCTGTGACTTCCTCCTGCCAGGGGATTTGGGGCTTTCTTG AAAGACAGTCCAAGCCCTGGATAATGCTTTACTTTCTGTGTTGAAGCACTGTTGGTTGTTTGGTTAGTGACTGATGTAAAACGGTTTTCT TGTGGGGAGGTTACAGAGGCTGACTTCAGAGTGGACTTGTGTTTTTTCTTTTTAAAGAGGCAAGGTTGGGCTGGTGCTCACAGCTGTAAT CCCAGCACTTTGAGGTTGGCTGGGAGTTCAAGACCAGCCTGGCCAACATGTCAGAACTACTAAAAATAAAGAAATCAGCCATGCTTGGTG CTGCACACTTGTAGTTGCAGCTCCTGGGAGGCAGAGGTGAGGGATCACTTAACCCAGGAGGCAGAGGCTGCACTGAGCCAGGATCACGCC ACTGCACTCTAGCCTGGGCAACAGTGAGACTGTCTCAAAAAAAAAAAAAGAGACAGGGTCTTCGGCACCCAGGCTGGAGTACAGTGCCAC AATCATGGCTCACTGCAGTCTTGAACTCATGGCCTCAAGCAGTCCTCCCTCAGCCTCCCAAGTAGAGGGGTTTATAGGCACGAGACCCTG CACCCAACCTAGAGTTGCCTTTTTTAAGCAAAGCAGTTTCTAGTTAATGTAGCATCTTGGACTTTGGGGCGTCATTCTTAAGCTTGTTGT GCCCGGTAACCATGGTCCTCTTGCTCTGATTAACCCTTCCTTCAATGGGCTTCTTCACCCAGACACCAAGGTATGAGATGGCCCTGCCAA GTGTCGGCCTCTCCTGTTAAACAAAAACATTCTAAAGCCATTGTTCTTGCTTCATACATCCTCCTTTGTGGCTTCCCACCCTTCTACTCC AACACGGGCCAGGCCATCTCCCCGGGGATGAAGAGGAGGATTCGCCTGGGCCAGTACGGCTTCCCCAATCCTGAGTGGTCAGAAGTCTCT GAGGATGCCAAGCAGCTGATCCGCCTCCTGTTGAAGACAGACCCCACAGAGAGGCTGACCATCACTCAGTTCATGAACCACCCCTGGATC AACCAATCGATGGTAGTGCCACAGACCCCACTCCACACGGCCCGAGTGCTGCAGGAGGACAAAGACCACTGGGACGAAGTCAAGGAGGAG ATGACCAGTGCCTTGGCCACTATGCGGGTAGACTACGACCAGGTGAAGATCAAGGACCTGAAGACCTCTAACAACCGGCTCCTCAACAAG AGGAGAAAAAAGCAGGCAGGCAGCTCCTCTGCCTCACAGGGCTGCAACAACCAGTAGCTCATGGGGCCTTGGAGGAGCCTGGCCTCTCAG CCTGCATAACAGACTGAAATGTGCTCAGGCCCTGGCCAGGAGGGCCCAGGGTCATTCTTTTAACAAAAGGATTATTTTGTTGTGTTTTAA TTTGTCACTCGGAACTTCAGGATGGAGGACCCTGACCCTAAACCTCCTTCAGATCTCTGGCCCAGGCTCAAGCCCTAGAGATGGGCAGGG CCTAGGGGCTGGGAGCTGCCTGCTGCCATAGCAGCACCTTTAGCTAGGTTGGCCCGAGTGAGGCCTCTGTGCTGTCCTGCCCTGGTGCAT GGCCTTAGCTTTCTAGGCCACTGGGAGTTGTGGCTGGGCTTCCCATCTTCCACAGAGACATCTCCCTGTGGGATGGGCAGATGGGCCTGG CCTTGAGAAAGGCATTGGCCATTGGTTGCCATGGTGACCAGGGACCACGTTGCTGCCTGTGAATGCTGAGTGAGCGAGTAAGGGAGGAGG GGCGATTGAGGGTTCACCTCTGCCTTGGGGAGGCTGATTTCTCACACACTGGCTGGCCCTCTCATTCTCACTCCTCCTTGGGCCCTGAGG CTGCTGGATCCGGTCTGCCTGCCTCCCTGTGCAGTCCAGCCCTGCCTTGCTGCAGCCCCAGCCCAGATGGCACTCAGCGCTCTCCCCTGA GGGAGTCCCTGGGCCTAGCCATCCCCTCACTATTCCCGACCCAAAGGGTGACTTTTCATCTGAACTTAAGGTGGGAGATATTTTTAACTT TTTTCCACTTTGGAAAATGTCACTGTGACAAAAGCCAGCATACTTTCCCTGCACCCATCTGCTCACCAGATCTCAGGCAGGAAAGCCCCT CTCTGTTGAAGTCAGGGGCTATCTTTTGGTATACTTGTGTGAAAGTGGCTGGTTGGGAGCAGAGCTAAGTGGCTTCCCATTAACCTGAGG TCTCTTTCTTTACTCTGGGTCAGACCTGAGGTTGGGGAAGGCGACTGAGCCATGCTCAGAATGTCTGGTCCTGGCTTGGGCCTGAGTAGG GCAGAGAGGGCCTTTCCTGGCTGATCAGAGCTTACCAGCCCCACCCCACCATGGTAGCCTTAGGGTGCTGAGTGCCTGATACTGCCTGAC AAGTGCCTGACACGCAGCCTAGTTCCTTCCTGGCCCCTCTCTCACTGGCTGGGAAACCCTAGACCATGTCAGATAGGACAACACTGCTGG >75915_75915_1_RPL13-MAPKAPK3_RPL13_chr16_89629431_ENST00000452368_MAPKAPK3_chr3_50683209_ENST00000446044_length(amino acids)=174AA_BP= MRWPCQVSASPVKQKHSKAIVLASYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for RPL13-MAPKAPK3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for RPL13-MAPKAPK3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for RPL13-MAPKAPK3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies